Susquehanna Fundamental Investments’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-136,683
| Closed | -$161K | – | 935 |
|
|
2025
Q1 | $161K | Sell |
136,683
-56,201
| -29% | -$66.3K | ﹤0.01% | 1010 |
|
|
2024
Q4 | $353K | Buy |
+192,884
| New | +$353K | 0.01% | 910 |
|
|
2022
Q1 | – | Sell |
-27,560
| Closed | -$564K | – | 1653 |
|
|
2021
Q4 | $564K | Sell |
27,560
-15,599
| -36% | -$319K | 0.01% | 867 |
|
|
2021
Q3 | $1.1M | Sell |
43,159
-41,220
| -49% | -$1.05M | 0.02% | 818 |
|
|
2021
Q2 | $2.95M | Sell |
84,379
-31,800
| -27% | -$1.11M | 0.05% | 467 |
|
|
2021
Q1 | $3.87M | Hold |
116,179
| – | – | 0.07% | 409 |
|
|
2020
Q4 | $3.01M | Buy |
116,179
+14,399
| +14% | +$374K | 0.05% | 489 |
|
|
2020
Q3 | $1.01M | Buy |
101,780
+16,280
| +19% | +$161K | 0.03% | 642 |
|
|
2020
Q2 | $295K | Buy |
+85,500
| New | +$295K | 0.01% | 745 |
|